Neoadjuvant therapy in melanoma with Georgina Long | 45 min

User Avatar
(0 review)
Free
MIA Ed_Thumbnail_ONJ_Neoadjuvant with GL

  • Neoadjuvant therapy in melanoma with Georgina Long | 45 min 0/1

    take Module

    In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine on pathological response and survival with neoadjuvant therapy in melanoma.

    This interview is from The Oncology Journal Club podcast series and the link will take you to the Oncology News Australia website.

    Please note that this podcast was accurate at the time of recording (February 2021) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

    SPEAKERS
    Professor Georgina Long AO Professor Georgina Long AO
    Co-Medical Director, Melanoma Institute Australia
    Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
    Declaration of Interest
    Professor Hans Prenen Professor Hans Prenen
    Medical Oncologist and Deputy Head of the Oncology Department at University Hospital Antwerp
     

Reviews

Average Rating

0
0 rating

Detailed Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Free